Da‐You Ma

498 total citations
31 papers, 341 citations indexed

About

Da‐You Ma is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Da‐You Ma has authored 31 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 14 papers in Molecular Biology and 5 papers in Toxicology. Recurrent topics in Da‐You Ma's work include Chemical Synthesis and Analysis (6 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Synthesis and biological activity (4 papers). Da‐You Ma is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Synthesis and biological activity (4 papers). Da‐You Ma collaborates with scholars based in China, Sweden and Ireland. Da‐You Ma's co-authors include Mei‐Xiang Wang, De‐Xian Wang, Luo Yang, Changqi Hu, Jie Pan, Zhi‐Tang Huang, Qi‐Yu Zheng, Renxiang Liu, Shuguang Wang and Jie Lin and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Organic Letters.

In The Last Decade

Da‐You Ma

28 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Da‐You Ma China 11 215 151 70 25 19 31 341
Mariia S. Kirillova Spain 10 617 2.9× 79 0.5× 71 1.0× 20 0.8× 49 2.6× 12 685
Lydie Coulombel France 11 410 1.9× 115 0.8× 97 1.4× 6 0.2× 13 0.7× 14 490
Andrew M. Camelio United States 9 237 1.1× 105 0.7× 36 0.5× 3 0.1× 27 1.4× 11 345
Elena M. Sánchez Spain 10 325 1.5× 67 0.4× 40 0.6× 4 0.2× 27 1.4× 14 396
Michael J. Di Maso United States 12 284 1.3× 58 0.4× 31 0.4× 6 0.2× 9 0.5× 21 388
Andrew W. Bridge United Kingdom 9 205 1.0× 92 0.6× 17 0.2× 4 0.2× 9 0.5× 14 323
Bo‐Wen Pan China 11 324 1.5× 104 0.7× 83 1.2× 2 0.1× 23 1.2× 47 455
Guilherme Álvaro Ferreira‐Silva Brazil 11 140 0.7× 167 1.1× 14 0.2× 7 0.3× 18 0.9× 24 339
Hui‐Chang Lin Taiwan 16 462 2.1× 222 1.5× 25 0.4× 3 0.1× 14 0.7× 39 594
Lekh Nath S. Gautam United States 8 238 1.1× 144 1.0× 30 0.4× 2 0.1× 47 2.5× 11 409

Countries citing papers authored by Da‐You Ma

Since Specialization
Citations

This map shows the geographic impact of Da‐You Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da‐You Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da‐You Ma more than expected).

Fields of papers citing papers by Da‐You Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Da‐You Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da‐You Ma. The network helps show where Da‐You Ma may publish in the future.

Co-authorship network of co-authors of Da‐You Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Da‐You Ma. A scholar is included among the top collaborators of Da‐You Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Da‐You Ma. Da‐You Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Tiao, Jiang Zhou, Xiaohe Liu, et al.. (2025). ASS1 inhibits liver cancer by promoting CAD ubiquitination and reversing the urea cycle and pyrimidine synthesis imbalance. Hepatology Communications. 9(9).
2.
Chen, Ling, Tiao Luo, Jijia Li, et al.. (2024). Synthesis and biological evaluation of novel isoxazoloquinone derivatives as potent STAT3-targeting antipsoriasis agents. Bioorganic Chemistry. 151. 107617–107617.
3.
Chen, Ling, Xu Deng, Tian Guang, et al.. (2024). Design, Synthesis, and Biological Activity of Novel Quinone Derivatives as Potent STAT3 Inhibitors for Psoriasis Treatment. Journal of Medicinal Chemistry. 67(17). 15438–15455. 2 indexed citations
4.
Chen, Ling, Hongdou Liu, Ting Peng, et al.. (2023). An Isoxazoloquinone Derivative Inhibits Tumor Growth by Targeting STAT3 and Triggering Its Ubiquitin-Dependent Degradation. Cancers. 15(9). 2424–2424. 8 indexed citations
5.
Chen, Ling, Zhiyong Luo, Lijun Liu, et al.. (2020). Synthesis and biological evaluation of novel isothiazoloquinoline quinone analogues. Bioorganic & Medicinal Chemistry Letters. 30(16). 127286–127286. 6 indexed citations
6.
Ma, Da‐You, et al.. (2020). Synthesis and anti-OXPHOS, antitumor activities of DLC modified spinosyn derivatives. Bioorganic & Medicinal Chemistry Letters. 30(9). 127047–127047. 3 indexed citations
8.
Peng, Yong, et al.. (2019). Co-Catalyzed decarbonylative alkylative esterification of styrenes with aliphatic aldehydes and hypervalent iodine(iii) reagents. Organic Chemistry Frontiers. 6(17). 3065–3070. 15 indexed citations
9.
Ma, Da‐You, et al.. (2018). Synthesis and antiproliferative activities of novel quartenary ammonium spinosyn derivatives. Bioorganic & Medicinal Chemistry Letters. 28(20). 3346–3349. 6 indexed citations
10.
Xu, Na, et al.. (2017). An Efficient Synthesis of Angelmarin and its Analogs. Natural Product Communications. 12(12). 1 indexed citations
11.
Norouzi‐Arasi, Hassan, et al.. (2016). Synthesis of Cr(III) Salen Complexes as Supramolecular Catalytic Systems for Ring‐Opening Reactions of Epoxides. ChemistrySelect. 1(8). 1789–1794. 4 indexed citations
12.
Liu, Lijun, et al.. (2015). The iodine-mediated highly regioselective synthesis of angular and linear naphthofuroquinones. Tetrahedron Letters. 56(48). 6730–6733. 8 indexed citations
13.
Liu, Lijun, et al.. (2015). A convenient synthesis of Lupeol from Betulin. Industrial Crops and Products. 74. 494–496. 4 indexed citations
14.
Ma, Da‐You, Hassan Norouzi‐Arasi, Esmaeil Sheibani, & Kenneth Wärnmark. (2010). Dynamic Supramolecular [(Salen)CrCl] Complexes as Efficient Catalysts for Ring Opening of Epoxides. ChemCatChem. 2(6). 629–632. 9 indexed citations
15.
Ma, Da‐You, De‐Xian Wang, Jie Pan, Zhi‐Tang Huang, & Mei‐Xiang Wang. (2008). Nitrile Biotransformations for the Synthesis of Highly Enantioenriched β-Hydroxy and β-Amino Acid and Amide Derivatives: A General and Simple but Powerful and Efficient Benzyl Protection Strategy To Increase Enantioselectivity of the Amidase. The Journal of Organic Chemistry. 73(11). 4087–4091. 50 indexed citations
17.
Ma, Da‐You, De‐Xian Wang, Qi‐Yu Zheng, & Mei‐Xiang Wang. (2006). Nitrile biotransformations for the practical synthesis of highly enantiopure azido carboxylic acids and amides, ‘click’ to functionalized chiral triazoles and chiral β-amino acids. Tetrahedron Asymmetry. 17(16). 2366–2376. 19 indexed citations
18.
Wang, Shuguang, Da‐You Ma, & Changqi Hu. (2005). Three New Compounds from the Aerial Parts ofCaragana sinica. Helvetica Chimica Acta. 88(8). 2315–2321. 25 indexed citations
19.
Wang, Shuguang, Da‐You Ma, & Chang‐Qi Hu. (2004). Two new oligostilbenes from Caragana sinica. Journal of Asian Natural Products Research. 6(4). 241–248. 13 indexed citations
20.
Ma, Da‐You, et al.. (2004). Three Stilbene Tetramers from the Roots of Caragana sinica. Chinese Journal of Chemistry. 22(2). 207–211. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026